PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-67.89%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-214.64%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
25.24%
Positive EBIT growth while ENPH is negative. John Neff might see a substantial edge in operational management.
51.95%
Positive operating income growth while ENPH is negative. John Neff might view this as a competitive edge in operations.
51.12%
Positive net income growth while ENPH is negative. John Neff might see a big relative performance advantage.
51.26%
Positive EPS growth while ENPH is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
51.26%
Positive diluted EPS growth while ENPH is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.33%
Share reduction more than 1.5x ENPH's 23.87%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.33%
Diluted share reduction more than 1.5x ENPH's 23.87%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-126.11%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-145.35%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
22.72%
Positive 10Y revenue/share CAGR while ENPH is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-46.40%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-58.19%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-589.71%
Negative 10Y OCF/share CAGR while ENPH stands at 90.40%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
25.26%
Below 50% of ENPH's 96.12%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-321.17%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-5856.79%
Negative 10Y net income/share CAGR while ENPH is at 87.97%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-45.21%
Negative 5Y net income/share CAGR while ENPH is 94.91%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-281.88%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-30.93%
Negative equity/share CAGR over 10 years while ENPH stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-46.59%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-36.42%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while ENPH stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-20.67%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
6.59%
Inventory growth well above ENPH's 5.78%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-5.27%
Negative asset growth while ENPH invests at 2.40%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-13.05%
We have a declining book value while ENPH shows 363.95%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
21.24%
Debt growth far above ENPH's 38.29%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-14.02%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
1.33%
We expand SG&A while ENPH cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.